MICHELLE RISING: Open Payments
NPI 1003362682 · CANDOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,308 in 168 payments from 46 companies in 2025. Trend: 2023 $2,594 · 2024 $2,587 · 2025 $3,308
Food & beverage: $3,133Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $324 |
| AstraZeneca Pharmaceuticals LP | 15 | $273 |
| Alexion Pharmaceuticals, Inc. | 6 | $264 |
| ABBVIE INC. | 14 | $258 |
| Eisai Inc. | 8 | $189 |
| Genentech USA, Inc. | 11 | $179 |
| Janssen Biotech, Inc. | 9 | $177 |
| E.R. Squibb & Sons, L.L.C. | 8 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| PFIZER INC. | 8 | $122 |
Products named: Lenvima, Voydeya, EPKINLY, Enhertu, LUTATHERA, OPDIVO, LYNPARZA, ULTOMIRIS.
Industry payments across NY — which companies pay providers there.
